Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss
- PMID: 8985286
- DOI: 10.1002/hep.510250132
Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss
Abstract
We prospectively withdrew prednisone in 28 adult patients who had stable graft function more than 2 years after orthotopic liver transplantation (OLTx) and had been on 5 mg/d prednisone for at least 6 months. Prednisone was decreased from 5 mg/d to 2.5 mg/d for 1 month then stopped completely. Cyclosporine monotherapy was maintained at a level of approximately 200 ng/mL (TDX). Nineteen patients had prednisone withdrawn without complications. Four (14.2%) had modest elevations in liver function tests (two biopsy proven mild rejections and two were not biopsied). These four were treated with methylprednisolone boluses and then withdrawal of steroids again. Prednisone was restarted in five patients because of generalized fatigue and body aches (n = 4) and colitis (n = 1). Steroids later were successfully withdrawn in two of these patients. After prednisone withdrawal, three of five insulin-dependent diabetic patients were able to discontinue insulin therapy and their glycosylated hemoglobin levels improved. Four of fourteen hypertensive patients were able to discontinue antihypertensive medicines. Mean serum cholesterol decreased from 222.6 +/- 43.3 to 188.3 +/- 33.3 mg/dL (P < .001). The number of patients with serum cholesterol levels > 220 mg/dL decreased from 13 to 4. A control group of 24 patients maintained on 5 mg/d prednisone at least 2 years after liver transplantation also was studied. In this group during the study period, no diabetic became normoglycemic, no patient decreased their antihypertensive medicine, and the mean serum cholesterol levels did not change significantly. We conclude that prednisone withdrawal using cyclosporine monotherapy late after liver transplantation does not lead to graft loss and decreases the prevalence of diabetes, hypertension, and hypercholesterolemia. Symptoms occurring during withdrawal may be minimized by earlier or slower tapering.
Similar articles
-
Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity.Transplantation. 1995 Nov 15;60(9):1057-60. Transplantation. 1995. PMID: 7491685
-
Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.Transpl Int. 2001 Dec;14(6):420-8. doi: 10.1007/s001470100008. Transpl Int. 2001. PMID: 11793040
-
Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.Liver Transpl Surg. 1999 Sep;5(5):375-80. doi: 10.1002/lt.500050514. Liver Transpl Surg. 1999. PMID: 10477838 Clinical Trial.
-
Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.Liver Transpl Surg. 1999 May;5(3):204-8. doi: 10.1002/lt.500050303. Liver Transpl Surg. 1999. PMID: 10226111
-
[Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].Cas Lek Cesk. 2000 Mar 1;139(4):115-9. Cas Lek Cesk. 2000. PMID: 10838741 Clinical Trial. Czech.
Cited by
-
Metabolic complications in liver transplant recipients.World J Gastroenterol. 2016 Jul 28;22(28):6416-23. doi: 10.3748/wjg.v22.i28.6416. World J Gastroenterol. 2016. PMID: 27605877 Free PMC article. Review.
-
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.World J Gastroenterol. 2014 Sep 14;20(34):12330-40. doi: 10.3748/wjg.v20.i34.12330. World J Gastroenterol. 2014. PMID: 25232269 Free PMC article. Review.
-
Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.World J Gastroenterol. 2000 Oct;6(5):636-642. doi: 10.3748/wjg.v6.i5.636. World J Gastroenterol. 2000. PMID: 11819666 Free PMC article. No abstract available.
-
Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study.Indian J Anaesth. 2016 Jul;60(7):463-9. doi: 10.4103/0019-5049.186016. Indian J Anaesth. 2016. PMID: 27512161 Free PMC article.
-
Metabolic and cardiovascular complications in the liver transplant recipient.Ann Gastroenterol. 2015 Apr-Jun;28(2):183-192. Ann Gastroenterol. 2015. PMID: 25830307 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical